OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Granulomatosis with polyangiitis presenting as obstructive uropathy and vasculitic myopathy	184
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study	88
Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis	86
Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study	80
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply	71
Boxer’s shape, an unusual finding in nailfold capillaroscopy	68
Correction to: Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis	64
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply	60
E44 Differences of hematological abnormalities between COVID-19 infection and multisystemic inflammatory syndrome (MIS-C)	59
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis–associated uveitis	59
Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis	59
P011 Rituximab and COVID-19 vaccines; are they fit for purpose?	56
29 Juvenile idiopathic arthritis and osteogenesis imperfecta: an exceptional association	55
P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis Register	55
67 Double impact: hypophosphatemic rickets and vitamin D intoxication	52
P114 Medication adherence to b/tsDMARDS remains sub-optimal in refractory rheumatoid arthritis	51
P173 The positive utility of PSAID-12 score in remote monitoring and the impact of gender and treatment on patient reported outcomes in psoriatic arthritis	50
E046 Lytic lesions; metastatic disease or gout?	48
P073 Functional investigation of Osteoarthritis-associated non-coding variants using CRISPR/Cas9-mediated perturbation of active enhancer regions	47
P058 Pneumocystis Jirovecii Infection in autoimmune inflammatory rheumatic diseases in Oxford	47
P107 Long-term efficacy of baricitinib in patients with rheumatoid arthritis with inadequate response to bDMARDs: results from RA-BEYOND up to 6.9-years of treatment	45
P041 Successful reversal of microvascular damage with standard therapy in a case of dermatomyositis overlap syndrome	44
E051 Audit of the management of patients over 75 with osteoporotic fragility fractures in primary care	44
P110 Challenges of meeting NICE guidance for rheumatoid arthritis in the modern era: a service audit	43
P043 Income-Related Health Inequality and Osteoarthritis Intervention Outcomes: a Cohort Study	43

E078 Inflammation modifies the effect of rheumatoid arthritis in overall mortality among females	42
26 Kawasaki’s disease vs systemic juvenile idiopathic arthritis, a diagnostic dilemma	42
P004 Empowering the reproductive choices of patients with rheumatic disease: using the BSR 2022 pregnancy guidelines audit tool to evaluate pre-conception medication advice	41
Comment on: Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: a nationwide cross-sectional study among more than 12 000 patients	40
OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years	39
P133 Experiences of people with digital ulcers through filmed interviews	39
P004 Temporal and regional variation in the initiation of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study	39
P174 Identifying patterns of fatigue across flares in patients with axial spondyloarthritis	38
P193 Bimekizumab improves key symptoms, disease activity and function in patients across the full spectrum of axial spondyloarthritis up to week 24: results from two phase 3 studies	38
54 Kawasaki disease: experience in a general paediatric department of the CHU de Annaba Algeria	38
P104 The role of occupational therapy for the self-management of rheumatoid arthritis: a mixed methods systematic review	37
Bezoar secondary to NSAID use in a patient with inflammatory arthritis	36
Enhancing diagnosis of gout with deep learning in dual-energy computed tomography: a retrospective analysis of crystal and artefact differentiation	36
High levels of EPSTI1 enhance IFN-β-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis	36
OA22 Methotrexate drug monitoring and referral patterns to Hepatology - can we improve detection and monitoring of hepatoxicity with methotrexate use?	36
Lupus serology: off target but still relevant to the treat-to-target strategy in systemic lupus erythematosus	36
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers—an observational study	36